688131.SH
皓元医药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 91.66
−5.88%Margins
Gross margin
48.1%
EBITDA margin
15.1%
EBIT margin
9.9%
Net margin
8.2%
FCF margin
7.2%
7.6%
Return on equity
3.8%
Return on assets
6.3%
Return on invested capital
0.47x
Asset turnover
CNY 386.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026